TherapeuticsMD
TXMD
TXMD
155 hedge funds and large institutions have $1.17B invested in TherapeuticsMD in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
+11
Holders Change %
+7.64%
% of All Funds
3.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
58
Reduced
31
Closed
14
Calls
$7.42M
Puts
$5.8M
Net Calls
+$1.62M
Net Calls Change
-$1.65M
Top Buyers
| 1 |
DCM
Daruma Capital Management
New York
|
+$29.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.1M |
| 4 |
BlackRock
New York
|
+$10.1M |
| 5 |
PA
Perceptive Advisors
New York
|
+$9.84M |
Top Sellers
| 1 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
-$5.96M |
| 2 |
D.E. Shaw & Co
New York
|
-$3.88M |
| 3 |
Morgan Stanley
New York
|
-$1.62M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.54M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.46M |
